Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A medical chart on a table in an examination room

Aug 12, 2026

AI tools now widely available in Oracle Health's patient portal

Oracle Health has launched its AI-powered patient portal, making it accessible to all U.S. electronic health record (EHR) customers, enhancing patient engagement and self-management.The new Oracle Health Patient Portal consolidates various health data from clinical records, providing patients with tools to inquire about their health conditions, tests, and treatments. This initiative aims to empower patients by offering clear, understandable information, which can lead to better health management
A cloud with a lock symbol representing secure data storage in health informatics.

Aug 12, 2026

Oracle Health's AI Powered Patient Portal: Architectural Design, Clinical Governance and Market Dynamics in the Acute Care EHR Ecosystem

Oracle Health has launched an AI-powered patient portal, enhancing consumer health informatics by integrating advanced AI models within its Electronic Health Record (EHR) ecosystem. This initiative aims to bridge the gap between complex clinical documentation and patient understanding, presenting a significant advancement in digital patient engagement.The portal operates within Oracle's secure cloud infrastructure, ensuring patient records remain protected while enabling real-time interactions t
A cell culture flask in a laboratory setting

Aug 12, 2026

Software Can Solve CGT’s Sectors Traceability Challenges

The integration of industrial software in cell and gene therapy (CGT) is pivotal for enhancing traceability throughout the production process, according to insights from Jonathan Wofford, CCO at Title21 Health Solutions.Wofford emphasizes that CGT manufacturing is characterized by intricate workflows and a variety of factors, including different collection methods, variable starting materials, and logistical challenges. These complexities necessitate seamless coordination among clinical operatio
Minimalist illustration of a sensor and digital twin in a dark palette

Aug 12, 2026

Five Steps to Enable Self-Optimizing Process Purification

The evolution of bioprocessing purification systems is on the horizon, with self-optimization as the next significant leap. However, this advancement faces challenges due to insufficient integration across various components and a lack of clarity in essential concepts.Self-optimized purification relies on a combination of technologies, including process analytical tools, sensors, digital twins, and real-time optimization. While biopharmaceutical processing is at the forefront of this evolution,
A stethoscope and circuit board silhouette representing diagnostic AI.

Aug 12, 2026

Aidoc teams with 12 health systems to tackle issues around diagnostics

Aidoc has launched a Diagnostic AI Consortium, uniting twelve prominent U.S. health systems to enhance the evaluation and governance of diagnostic AI technologies.The consortium includes major players like Advocate Health, Cedars-Sinai, and Mount Sinai, with a focus on creating shared standards for the deployment and assessment of diagnostic AI. Aidoc's CEO, Elad Walach, emphasized the importance of collaboration in developing AI tools that are rigorously validated for clinical use and capable o
A test tube with green liquid in a lab setting

Aug 12, 2026

Australia, AI, and Autolomous

Australia is rapidly evolving its biotech landscape, particularly through the integration of AI technologies, positioning itself as a key player in the Oceanic and APAC markets.By 2025, the necessity for AI in biotechnology has become clear, with companies striving to enhance development timelines and operational efficiency. Australia stands out with existing AI policies that facilitate this transition, aiming to attract global investments and talent. Recent initiatives, like the AUS$238 million
A clinical trial vial and notebook in a dimly lit lab setting.

Aug 12, 2026

AI clinical monitoring agent can deliver up to 82 times the ROI in oncology: report

A recent analysis from the Tufts Center for the Study of Drug Development reveals that an AI clinical monitoring agent can yield an impressive return on investment (ROI) of up to 82 times in oncology trials, with potential net financial gains reaching $21 million per drug development program.The study assessed the digital trial platform Medable’s clinical monitoring agent, focusing on its expected net present value (eNPV). Findings indicated significant eNPV gains across various trial phases: ap
Press release cover image

Aug 12, 2026

Press release

Noble Secures New Patent for AI-Powered Sound Detection in Drug Delivery and Diagnostic Devices

New patent helps verify correct device operation, which may support patient confidence and adherence through AI-enabled performance feedbackCRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Noble, an Aptar Pharma company providing patient-centered solutions that support the safe and effective use of drug delivery and diagnostic devices, today announced the issuance of a new U.S. patent covering an artificial intelligence-enabled method for detecting, analyzing and classifying sound output from drug delivery
Press release cover image

Aug 12, 2026

Press release

Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging

TORONTO, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”) (TSXV: VPT; OTC: VPTDF), a leader in AI-assisted cardiac imaging, today announced the next phase of its commercial strategy for VMS+™ 4.0, its FDA-cleared platform that turns standard heart-ultrasound images into three-dimensional cardiac measurements. The Company is expanding subscription-based access, hospital demonstrations, and customer-engagement programs to help more hospitals evaluat
Press release cover image

Aug 12, 2026

Press release

Tris Pharma Expands Support for People Living with ADHD Through New Partnerships with Calm Health and ADHD Central

MONMOUTH JUNCTION, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Tris Pharma, Inc., a commercial-stage biopharmaceutical company focused on developing innovative therapies for unmet needs, today announced two new partnerships aimed at enhancing the treatment experience for individuals living with Attention-Deficit/Hyperactivity Disorder (ADHD). Through collaborations with Calm Health and ADHD Central, Tris Pharma is extending support beyond prescription treatment by providing patients and their care
A minimalist representation of a medical cross symbolizing healthcare and AI integration.

Aug 12, 2026

Clinical Grade AI Triage and Patient Navigation in European Healthcare: Market Analysis, Regulatory Drivers, Funding Dynamics and M&A Outlook

The European healthcare sector is experiencing a significant transformation as it shifts from traditional digital solutions to advanced artificial intelligence (AI) systems for patient triage and navigation. This change is largely driven by workforce shortages, growing emergency department demands, and an increase in chronic diseases.AI technologies are now being integrated into healthcare infrastructures to assess symptoms, prioritize clinical risks, and direct patients to suitable care options
Press release cover image

Aug 12, 2026

Press release

Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers

Phase I trial in Germany will support treatment response monitoring for Kupando Therapeutics’ investigational immunotherapy using Latitude MRD testingAUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a new collaboration regarding a Phase 1 clinical trial, sponsored by Kupando Therapeutics.Under the agreement, Natera’s Latitude tissue-free assay for molecular residual disease (MRD) detection will be used in Kupand